
Kerala's '2-Rupee Doctor' AK Rairu Gopal Dies At 80
For over five decades, Dr Gopal, who ran a small clinic from his home in Kannur, was a beacon of hope for the underprivileged. For many years, he charged a mere Rs 2 for a consultation, a fee so nominal it earned him his enduring nickname.
Though his fee eventually increased to Rs 40-50, it remained a fraction of the cost at other clinics, ensuring that no patient was ever turned away due to financial constraints. He often provided free medicines to those who couldn't afford them.
Dr Gopal's dedication went beyond his low fees. He would begin seeing patients as early as 3 am to accommodate daily wage labourers, students, and others who needed to get to work or school. He sometimes treated up to 300 people a day, with queues forming outside his home long before dawn. His compassionate approach and humble lifestyle earned him profound respect throughout the community.
Kerala Chief Minister Pinarayi Vijayan described Dr Gopal as "the people's doctor", noting that his readiness to serve for such a nominal fee was a source of "immense relief" for poor patients.
Dr Gopal, who was honoured with the IMA award for the best family doctor in the state, had to close his clinic in May 2024 due to declining health, a decision that deeply saddened his patients. His funeral took place on Sunday at Payyambalam, as the community bid farewell to a man who proved that healing is a service, not a business.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Economic Times
11 minutes ago
- Economic Times
Stock Radar: Syngene International showing signs of momentum after falling 26% from highs; what should investors do?
Syngene International Ltd, a player in the healthcare space, has gained momentum over the past month, helping the stock reclaim key moving averages — a sign that the bulls are trying to take traders with a high-risk profile can look to buy the stock for a target of Rs 761-846 in the next couple of months, suggest stock hit a high of Rs 960 on December 2, 2024, but it failed to hold the momentum. It closed at Rs


Time of India
3 hours ago
- Time of India
Prostate health in focus as BPH drug demand rises in Gujarat
Ahmedabad: The sale of drugs used to treat benign prostatic hyperplasia (BPH)—a non-cancerous enlargement of the prostate gland—has surged by 70% over the past four years, indicating a significant rise in cases across the state. According to data from Pharmarack, the moving annual total (MAT) for BPH drugs was Rs 55.24 crore in June 2021, which rose to Rs 93.93 crore in June this year. The MAT for the overall urology segment also saw a 42% increase, from Rs 115.22 crore to Rs 164.2 crore during the same period. You Can Also Check: Ahmedabad AQI | Weather in Ahmedabad | Bank Holidays in Ahmedabad | Public Holidays in Ahmedabad "BPH affects a significant portion of men aged 50 and above, causing urinary difficulties and impacting quality of life. While the condition has always existed, the sharp rise in diagnosed cases and medical interventions reflects broader trends," said a pharmaceutical distributor who requested anonymity. Industry sources said that pharma companies have improved drug delivery through fixed-dose combinations, leading to better patient compliance and outcomes. The most common prescriptions now include alpha-blockers and 5-alpha-reductase inhibitors, which help alleviate symptoms and slow further prostate growth, Pharmarack data indicated. According to urologists in Ahmedabad, men are increasingly addressing symptoms of an enlarged prostate rather than ignoring them. The stigma around men's urological health is gradually diminishing, especially in urban and semi-urban areas. Dr Rohit Bhattar, a uro-onco surgeon at a city-based private hospital, said, "There has been a significant rise in BPH cases over the past decade. While traditionally considered a disease of old age, we are now seeing some patients even under the age of 50, often due to other health conditions and lifestyle factors. Greater awareness today also plays a role compared to a decade ago." While metros and Tier-I cities initially drove demand for BPH drugs, pharmaceutical industry sources report that Tier-II cities and rural areas are now seeing growing traction. Dr Hemang Bakshi, another uro-onco surgeon, noted, "The rise in drug sales must be viewed in the context of increased life expectancy. Medications are often prescribed to maintain or enhance prostate function over time. Since onset typically occurs around the age of 60, patients may remain on treatment for several years. This extended treatment duration is a contributing factor. We've certainly seen a decadal rise in the incidence of the condition. " Experts say improvements in healthcare access and preventive diagnostics in Gujarat have made a noticeable impact. Routine check-ups, ultrasounds, and PSA tests are increasingly being used to detect prostate issues at earlier stages.


Time of India
4 hours ago
- Time of India
6 PHED engrs served notice over 150 crore tubewell scam in Jalore
Jaipur: Public health engineering department (PHED) has issued notices to six engineers of the department, including a retired engineer, for alleged involvement in a scam of Rs 150 crore. Officials said these engineers reportedly gave Operations and Maintenance (O&M) tenders to two firms for more than 900 tubewells in Jalore district when they were entitled to O&M of only 20 tubewells. "We took up the issue with PHED minister Kanhaiya Lal Choudhary. Following his instructions, we are going to take major steps against these accused engineers. We will also lodge complaints with police in this regard," disclosed a senior PHED official Wednesday. An official of the department claimed that the accused—then executive engineers Umesh Kumar Meena, Shyam Bihari Bairwa, Jitendra Trivedi, Hemant Kumar Bairwa, Ashish Dwivedi (retd), and Hemant Kumar Vaishnav—gave the work orders for O&M of 981 tubewells on Aug 12, 2022, to two firms—MM Construction and MS Raj Enterprise. "In gross violation of norms, the then superintendent engineer of the circle issued this work order for 981 tubewells. The two firms should have got work orders for only 20 tubewells. For the last three years, the department is unnecessarily wasting money on O&M expenditure for such a huge number of additional tubewells. The department has also blacklisted the two firms," the official added. Investigation revealed that PHED bore O&M expenditure for around 3,500 tubewells in Jalore for the last three years, when the actual number of tubewells of the department in the district was only close to 1,500.